METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ErbB2 POSITIVE CANCERS
AssigneeHealth Research, Inc.
InventorsYuesheng ZHANG, Lu YANG, Yun LI
Life of this patent
Estimating the term…
Abstract
Provided are compositions and methods for prophylaxis and/or therapy of ErbB2-positive cancer. The compositions include pharmaceutical preparations that contain isolated or recombinant or modified peptidase D (PEPD) proteins. The methods include prophylaxis and/or therapy of ErbB2-positive cancer by administering a PEPD to an individual who has or is at risk for developing ErbB2-positive cancer.
Claims11
A pharmaceutical preparation for use in prophylaxis and/or therapy of ErbB2-positive cancer comprising an isolated or recombinantly produced peptidase D (PEPD) and at least one pharmaceutically acceptable carrier.
A product for use in prophylaxis and/or therapy of ErbB2-positive cancer comprising at least one sealed container which contains a pharmaceutical preparation comprising peptidase D (PEPD), wherein the product comprises printed material which provides an indication that the pharmaceutical preparation is for use in prophylaxis and/or therapy of ErbB2-positive cancer in an individual.
Dependencies are inferred from the claim text.